We investigated the interaction between activated cat polymorphonuclear neutrophils (PMNs) and coronary vascular endothelial cells in vitro. It was shown that 1) 90 minutes of low-flow perfusion without reperfusion had no deleterious effects on endothelium-dependent vasodilation, whereas 90 minutes of low-flow perfusion and 20 minutes of reperfusion with a blood cell-free solution induced a 20-25% endothelial dysfunction; 2) activated PMNs produced endothelium-dependent vasoconstriction in coronary artery rings isolated from cat hearts undergoing 90 minutes of low-flow perfusion and 20 minutes of reperfusion with a blood cell-free Krebs-Henseleit solution; 3) addition of the superoxide free radical scavenger, superoxide dismutase (150 ,ug/ml), or an antibody directed against CD18 of PMN adherence glycoprotein complex (MAbR15.7, 20 ,ug/ml) attenuated PMN-induced vasoconstriction significantly, but addition of a hydroxyl radical scavenger [N-(2-mercaptopropionyl)-glycine, 150 ,ug/ml], a cyclooxygenase inhibitor, or a lipoxygenase inhibitor had no protective effect; 4) exposure of rings to a superoxide radical-generating system (i.e., xanthine and xanthine oxidase) produced significant vasoconstriction that was similar to that observed with activated PMNs and was inhibited by superoxide dismutase; and 5) activated PMNs produced a marked coronary endothelial dysfunction characterized by a decreased response to the endotheliumdependent vasodilators acetylcholine and A23187. Addition of either superoxide dismutase or MAbR15.7 protected against endothelial dysfunction. These results indicate that activated PMNs produce significant vasoconstriction and endothelial dysfunction in coronary arteries isolated from low-flow perfusion-reperfused hearts. These effects appear to be mediated primarily by superoxide radicals generated by activated PMNs that either inactivate or inhibit the synthesis and release of endothelium-derived relaxing factor. We conclude that activated PMNs are able to induce endothelial dysfunction by releasing free radicals and possibly other substances. (Circulation Research 1991;69:95-106) T he endothelium plays a significant role in the regulation of vasomotor tone, prevention of intravascular thrombosis, and modulation of leukocyte function through secretion of bioactive substances such as prostacyclin and endotheliumderived relaxing factor (EDRF). 
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Materials and Methods Isolation of Cat Neutrophils
PMNs were isolated by a procedure modified from that of Lafrado and Olsen.21 Peripheral blood (60 ml) was collected from the femoral artery of pentobarbital-anesthetized (30 mg/kg i.v.) adult male cats and was anticoagulated with citrate/phosphate/dextrose solution (Sigma Chemical Co., St. Louis) (1.4:10, vol/vol anticoagulant to whole blood) into roundbottom polycarbonate centrifuge tubes (Nalge Co., Rochester, N.Y.). Platelet-rich plasma was obtained by centrifuging blood at 400g for 20 minutes in an Econospin Tabletop Swinging Bucket centrifuge (Sorvall Instruments, Wilmington, Del.). Plateletrich plasma was decanted and centrifuged at 2,500g for 10 minutes to obtain platelet-poor plasma, which then was mixed with isotonic Percoll (Sigma) (9 vol Percoll: 1 vol 1.5 M NaCl) to produce Percoll-platelet-poor plasma density gradients of 80%, 62%, and 50%. Five milliliters of 4% dextran (average molecular weight, 60,000-90,000) (Sigma) was added to the erythrocyte-leukocyte pellet from the initial 400g centrifugation. After mixture by inversion, the erythrocytes were allowed to settle for 50 minutes. The leukocyte-rich upper layer was collected and centrifuged at 2,500g for 10 minutes. The pellet was resuspended in 1 ml 0.9% NaCl and layered onto the Percoll-platelet-poor plasma gradient. Centrifugation then was performed at 400g for 40 minutes at 4°C in a Sorvall RC2-B refrigerated centrifuge. PMNs were collected from the 62-80% interface and washed twice with 0.9% NaCl before being assayed for viability using trypan blue exclusion. PMN preparations obtained by this method typically were more than 95% pure and more than 95% viable. Isolated Perfused Heart Adult male cats (2.5-3.4 kg) were anesthetized with pentobarbital sodium (30 After a 5-minute period of equilibration at constant flow, hearts were subjected to a 90-minute period of low-flow perfusion by reducing the flow to 15% of control, followed by 20 minutes of reperfusion at the original flow. Control hearts were perfused at a constant flow of 30-35 ml/min for 110 minutes. Hearts then were removed from the perfusion apparatus and placed into warmed K-H solution for isolation of coronary artery segments.
Isolated Coronary Artery Ring Preparation
Both left anterior descending and left circumflex coronary artery segments were removed and placed into warmed K-H solution. Isolated coronary vessels were cleaned of fat and connective tissue and cut into rings 2-3 mm in length and placed in 5-ml tissue baths. The rings then were mounted on stainless steel hooks and connected to Grass FT-03 force displacement transducers to record changes in force on the oscillographic recorder. The baths were filled with 5 ml K-H solution and aerated at 37°C with a gas mixture of 95% 02-5% CO2. Coronary rings initially were stretched to give a preload of 0.5 g force and were equilibrated for 60-90 minutes. During this period, the K-H solution in the tissue baths was replaced every 15-20 minutes. After equilibration, the rings were exposed to 20 nM U46619 (9,11-epoxymethano-prostaglandin H2, The Upjohn Co., Kalamazoo, Mich.), a thromboxane A2 mimetic, to generate approximately 0.5 g developed force. Once a stable contraction was obtained, 0.1, 1, 10, and 100 nM acetylcholine was added to the bath. After the response stabilized, the rings were washed and allowed to equilibrate to baseline once again. The procedure was repeated with another endotheliumdependent vasodilator, A23187 (1, 10, 100, and 1,000 nM), and then with the endothelium-independent vasodilator acidified NaNO2 (0.1, 1, 10, and 100 ,M). The data obtained were defined as Pre-PMN xanthine oxidase responses.
Once the original baseline was restored after washing several times, autologous PMN Vasoactive responses of coronary rings isolated from perfused cat hearts subjected to either constant-flow perfusion for 110 minutes (control heart), 90 minutes of low-flow perfusion without reperfusion, or 90 minutes of low-flow perfusion and 20 minutes of reperfusion with blood cell-free K-H solution were tested with the endothelium-dependent vasodilators, acetylcholine and A23187, and endothelium-independent vasodilator, NaNO2. Coronary rings from control hearts exhibited full relaxation to acetylcholine (100 nM), A23187 (1 ,M), and NaNO2 (100 ,uM). Rings isolated from the hearts subjected to 90 minutes of low-flow perfusion without reperfusion showed normal vasorelaxant responses to both the endothelium-dependent vasodilators and the endothelium-independent vasodilator. No statistical difference was observed in the vasorelaxant responses between the rings from 90-minute lowflow-perfused hearts and control hearts. However, when rings from the hearts subjected to 90 minutes of low-flow perfusion and 20 minutes of reperfusion with blood cell-free K-H solution were tested, a significant endothelial dysfunction was observed. These rings relaxed to acetylcholine and A23187, 74±6% and 80±6%, respectively, which are significantly lower values than the comparable responses in rings isolated from control hearts (i.e., 90±4% and 91±3% respectively, p<0.02). In contrast, vasorelaxation to the endothelium-independent dilator NaNO2 was normal in rings obtained from these reperfused hearts ( Figure 1 ). These results indicate that 90 minutes of low-flow perfusion without reperfusion had no deleterious effect on the synthesis and release of EDRF, whereas 90 minutes of low-flow perfusion plus 20 minutes of reperfusion with a blood cell-free solution induced a 20-25% degree of endothelial dysfunction, presumably because of changes induced within the endothelial cells themselves.
Vasoconstrictor Responses to Neutrophils
Addition of autologous PMNs (lx 104 to 5 x 105 cells/ml) or of f-MLP (10-200 nM) separately to the artery chambers had no detectable effect on either basal vascular tone or endothelium-dependent vasodilation of rings isolated from hearts subjected to 90 minutes of low-flow perfusion plus 20 minutes of reperfusion (data not shown). However, when the PMNs in the chambers were activated with f-MLP, consistent vasoconstrictor responses occurred, which reached maximal force 2-5 minutes after addition of f-MLP and remained at this plateau for the remainder of the 20-minute observation period. In further studies, free radical inhibitors and generators were used as tools to investigate the role of oxygen-derived free radicals in producing the activated PMN-induced endothelial dysfunction. Addition of hSOD (150 ,ug/ml), a superoxide radical scavenger, significantly inhibited PMN-induced endothelial dysfunction, but addition of MPG (150 ,ug/ml), a hydroxyl radical scavenger, had no effect on PMN-induced endothelial dysfunction (Figures 3 and  4) . When the superoxide radical generator xanthine and xanthine oxidase were added to the chambers by themselves and the chambers were incubated for 20 minutes, a significant endothelial dysfunction was obtained similar to that observed with activated PMNs. Addition of either the superoxide free radical scavenger hSOD or the xanthine oxidase inhibitor allopurinol markedly attenuated the resulting endothelial dysfunction (Figures 5 and 6) (Figures 7 and 8 ).
Moreover, we tested the ability of MAbR15.7 to alter PMN adherence to cat coronary vascular endothelium using PKH-2, a fluorescent dye that was incorporated into PMN cell membranes. Very few PMNs adhered to endothelium when nonstimulated PMNs were used (e.g., without f-MLP): 2 (Figure 9 ). These results indicate that the activated PMN-induced vasoconstrictor response is endothelium dependent and is related to EDRF inhibition.
In additional experiments, we observed that addition of 100 nM leukotriene B4 to activate PMNs also induced a significant endothelium-dependent vasoconstriction (0.28+±0.03 g, n=8; not significantly different from 0.30±0.02 g, n=40, obtained for f-MLP), indicating that activated PMN-induced vasoconstriction was not f-MLP specific.
To determine whether exposure of the rings to acetylcholine and A23187 may influence subsequent PMN-induced vasoconstriction, we observed the effect of activated PMNs on basal vascular tone in another seven rings that had not been exposed to either acetylcholine or A23187. We found that acti- observed in rings exposed to acetylcholine and A23187 and then given f-MLP-activated PMNs. To identify the mechanism by which activated PMNs induce vasoconstriction, we also observed the effect of inhibitors and activators of potential humoral mediators on the contractile response of coronary rings to activated PMNs. The results obtained are summarized in Table 1 . Addition of hSOD significantly inhibited activated PMN-induced vasoconstriction, whereas addition of MPG had no significant protective effect (Figure 3) . Moreover, exposure of the coronary rings to the superoxide radical-generating system xanthine and xanthine oxidase produced a degree of vasoconstriction similar to that observed with activated PMNs. Addition of hSOD or allopurinol to this free radical-generating system inhibited vasoconstriction ( Figure 5 ). Incubation of MAbR15.7 with the PMNs also significantly attenuated activated PMN-induced vasoconstriction, whereas MAbR3. 1 had no detectable effect on these changes (Figure 7 ).
Discussion
We have observed that coronary arteries isolated from hearts subjected to 90 minutes of low-flow perfusion and 20 minutes of reperfusion with bloodfree K-H solution exhibited a 25% endothelial dysfunction, a value less than that observed in coronary rings obtained from in vivo ischemia and reperfused coronary arteries.6 Second, we observed that activated PMNs produced an endothelium-dependent vasoconstriction in cat coronary arteries that appears to be mediated through the generation of superoxide radicals by activated and presumably adhered PMNs, because addition of the superoxide free radical scavenger hSOD or an antibody that inhibits PMN adherence to endothelial cells significantly attenuated PMN-induced vasoconstriction. Moreover, addition of a superoxide radical-generating system (i.e., xanthine and xanthine oxidase) induced vasoconstrictor responses similar to those observed in the presence of activated PMNs. Third, we have demonstrated that activated cat PMNs induce a sustained endothelial dysfunction that seems to be mediated by superoxide radicals and which remains after the activated PMNs have been washed out of the bathing medium.
It is well recognized that PMN migration and accumulation may exert deleterious effects on local blood flow regulation in previously ischemic reperfused regions. Aggregated PMNs can physically obstruct capillary flow and induce a "no-reflow" phenomenon.23 PMNs also can produce significant vasoconstriction, resulting in an increase in coronary vascular resistance and a decrease in local blood flow.19,20 However, the exact mechanisms by which PMNs induce vasoconstriction are not fully understood. Recently, Ohlstein and Nichols19 observed that f-MLP-activated PMNs produce endotheliumdependent vasoconstriction in control rabbit aortic segments. This response appeared to be mediated through the generation of superoxide radicals and is blocked by SOD. In this regard, Nishida et a120 reported that unactivated PMNs can vasoconstrict canine coronary arteries. This vasoconstriction was reported to be mediated by generation and release of leukotriene C4 from endothelial cells through an endothelial-leukocyte leukotriene A4 steal mechanism. Addition of 5-lipoxygenase inhibitors (i.e., esculetin and AA861) inhibited, whereas addition of hSOD had no effect on, the PMN- triene B4 produce significant vasoconstriction in lowflow perfusion-reperfused cat coronary arteries, which mainly is mediated by generation of superoxide free radicals from activated PMNs rather than by arachidonate metabolites.
There are several possible explanations for the differences between these studies. First, PMNs were activated with chemotactic peptide in Ohlstein and Nichols'9 and in our experiments, whereas Nishida et a120 did not activate their PMNs. It is highly probable that activated PMNs produce more free radicals than nonactivated PMNs. Second, we and Ohlstein and Nichols'9 used a higher concentration of hSOD (150-450 units/ml), whereas Nishida et a120 used 60 units/ml hSOD. Third, we studied PMN-induced vasoconstriction primarily in low-flow perfusion-reperfused coronary arteries, which may be more sensitive to free radicals than normal coronary arteries. Fourth, most lipoxygenase inhibitors have antioxidant activity that can inhibit free radical generation or scavenge free radicals in addition to blocking the production of lipoxygenase products.24 In our experiments, when a lipoxygenase inhibitor devoid of antioxidant activity was tested (i.e., diethylcarbamazine), no inhibition of the PMN-induced vasoconstrictor effect was observed.
Basal tone is the result of the balance between vasoconstrictor and vasodilator factors. It is well recognized that EDRF released from normal endo- II I PMN, polymorphonuclear neutrophils (5 x 105 cells/ml); f-MLP, formyl-methionyleucylphenylalanine (100 nM); hSOD, superoxide dismutase (150 ,ug/ml); MPG, N-(2-mercaptopropionyl)-glycine (150 ,ug/ml); X, xanthine (100 ,uM); XO, xanthine oxidase (20 milliunits/ml); Allo, allopurinol (50 ,uM); MAbR15.7, monoclonal antibody (20 ,ug/ml); MAbR3.1, control isotype antibody (20 ,ug/ml).
producing endothelial dysfunction in feline coronary arteries.
It was reported recently that activated PMNinduced endothelial injury is mediated mainly by PMN-derived proteases, particularly elastase.18,40 However, these investigators used a long period of incubation (i.e., 8 hours) with a high PMN-to-endothelium ratio (15:1) and used 51Cr release and endothelial cell detachment as indexes of endothelial injury. Our previous study has demonstrated that endothelial dysfunction manifested by a marked loss of endothelium-dependent vasorelaxation occurs much earlier than any significant morphological changes.6 Thus, it is possible that free radicals generated by endothelial cells and PMNs during the early stage of reperfusion induce mainly functional changes in the endothelium, whereas proteases generated by PMNs, which interact with endothelial cells for a longer time, result in morphological injury to endothelial cells.
In conclusion, we have demonstrated that coronary arteries subjected to 90 minutes of low-flow perfusion and 20 minutes of reperfusion with a blood cell-free solution exhibit a 20-25% degree of endothelial dysfunction. Addition of activated PMNs produces a significant endothelium-dependent vasoconstriction. This appears to be mediated by the generation of superoxide free radicals, which probably is not due to generalized oxidative endothelial injury (e.g., in which H202 and hydroxyl radicals would participate) but rather to a specific degradation of EDRF by superoxide radicals. Exposing these rings to activated PMNs for 20 minutes results in an additional significant endothelial dysfunction, indicating that not only are PMNs important in ischemia and reperfusioninduced myocyte injury, but they also play a potential role in the endothelial dysfunction associated with ischemia and reperfusion.
